Richard R. De Luca Merck & Co., Inc. (MRK) insider trading activity

Richard R. De Luca is EVP&Pres, Merck Animal Heallth of Merck & Co., Inc.. Currently has a direct ownership of 178,992 shares of MRK, which is worth approximately $14.8 Million. The most recent transaction as insider was on Jan 27, 2025, when has been sold 25,438 shares (Common Stock) at a price of $97.94 per share, resulting in proceeds of $2,491,397. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 179K

0% 3M change

19.04% 12M change

Total Value Held $14.8 Million

Richard R. DeLuca Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 27 2025	BUY Grant, award, or other acquisition	$2,491,397 $97.94 p/Share	25,438 Added 12.44%	178,992 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$1,703,533 $127.51 p/Share	13,360 Reduced 8.16%	150,359 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	$3,458,836 $127.51 p/Share	27,126 Added 14.21%	163,719 Common Stock
Jan 22 2024	BUY Grant, award, or other acquisition	$2,782,241 $119.43 p/Share	23,296 Added 14.64%	135,782 Common Stock
Nov 08 2023	SELL Open market or private sale	$4,602,729 $105.03 p/Share	43,823 Reduced 28.17%	111,763 Common Stock
May 01 2023	SELL Open market or private sale	$8,752,839 $116.03 p/Share	75,436 Reduced 32.81%	154,492 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	$4,227,433 $56.04 p/Share	75,436 Added 24.7%	229,928 Common Stock
Apr 28 2023	SELL Open market or private sale	$7,608,745 $115.0 p/Share	66,163 Reduced 29.98%	154,492 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	$4,106,737 $62.07 p/Share	66,163 Added 23.07%	220,655 Common Stock
Jan 23 2023	BUY Grant, award, or other acquisition	$1,717,204 $109.88 p/Share	15,628 Added 9.24%	153,500 Common Stock
Oct 28 2022	SELL Open market or private sale	$16,498,484 $100.26 p/Share	164,557 Reduced 54.57%	136,977 Common Stock
Oct 28 2022	BUY Exercise of conversion of derivative security	-	164,557 Added 35.31%	301,534 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	$1,173,661 $73.51 p/Share	15,966 Added 10.65%	133,896 Common Stock
Nov 04 2021	SELL Open market or private sale	$2,692,293 $90.4 p/Share	29,782 Reduced 20.3%	116,929 Common Stock
Nov 04 2021	BUY Exercise of conversion of derivative security	-	29,782 Added 16.87%	146,711 Common Stock
Oct 29 2021	SELL Open market or private sale	$11,856,061 $87.56 p/Share	135,405 Reduced 53.66%	116,929 Common Stock
Oct 29 2021	BUY Exercise of conversion of derivative security	-	135,405 Added 34.92%	252,334 Common Stock
Feb 26 2021	BUY Grant, award, or other acquisition	$1,852,536 $72.62 p/Share	25,510 Added 18.28%	114,051 Common Stock
Feb 28 2020	BUY Grant, award, or other acquisition	$1,100,473 $76.56 p/Share	14,374 Added 14.2%	86,856 Common Stock
Aug 09 2019	SELL Open market or private sale	$546,873 $85.09 p/Share	6,427 Reduced 8.25%	71,523 Common Stock
Aug 09 2019	BUY Exercise of conversion of derivative security	-	6,427 Added 7.62%	77,950 Common Stock
Aug 08 2019	SELL Open market or private sale	$2,694,732 $85.01 p/Share	31,699 Reduced 30.71%	71,523 Common Stock
Aug 08 2019	BUY Exercise of conversion of derivative security	-	31,699 Added 23.49%	103,222 Common Stock
May 03 2019	SELL Open market or private sale	$2,800,000 $80.0 p/Share	35,000 Reduced 33.0%	71,064 Common Stock
May 03 2019	BUY Exercise of conversion of derivative security	$1,375,150 $39.29 p/Share	35,000 Added 24.81%	106,064 Common Stock

RRD

Richard R. De Luca

EVP&Pres, Merck Animal Heallth

Kenilworth, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRK shares.

Notify only if

Value

Insider Trading

Get notified when an Merck & Co., Inc. insider buys or sells MRK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Merck & Co., Inc.

Track Activities on MRK

Account